Blume-Jensen Peter

CIK 00019504991 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001950499

Recent Transactions

33 trades

Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-11-21$2.30/sh−19,904→ 2,046,771 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-11-14$2.24/sh−490→ 314,706 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-11-14$2.24/sh−59,765→ 2,066,675 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-08-21$1.32/sh−19,905→ 2,126,440 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-08-14$1.39/sh−490→ 315,196 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-08-14$1.39/sh−59,766→ 2,146,345 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-05-21$1.15/sh−19,904→ 2,206,111 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-05-14$1.14/sh−59,766→ 2,226,015 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-05-14$1.14/sh−491→ 315,686 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-03-01+140,540→ 140,540 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-03-01+390,390→ 390,390 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-02-21$5.54/sh−19,904→ 2,285,781 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-02-14$5.42/sh−579→ 316,177 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-02-14$5.42/sh−37,152→ 2,305,685 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-11-21$6.44/sh−19,910→ 2,342,837 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-11-14$7.92/sh−490→ 316,756 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-11-14$7.92/sh−59,766→ 2,362,747 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-08-21$9.19/sh−79,616→ 2,422,513 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-08-14$7.02/sh−59,765→ 2,502,129 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-05-14$8.36/sh−54,918→ 2,561,894 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-03-01+90,090→ 90,090 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-03-01+225,226→ 225,226 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-02-14$3.40/sh−41,861→ 2,616,812 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2023-11-14$5.08/sh−239,023→ 2,658,673 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2023-08-21+493,994→ 2,897,696 total
Exercise/Conversion
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2023-05-31−33,605→ 90,855 total
Exercise/Conversion
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2023-05-31$3.88/sh+33,605→ 2,403,702 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2022-11-14+180,269→ 180,269 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+934,731→ 1,806,588 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+503,419→ 2,310,007 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2022-11-14+80,120→ 80,120 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+26,707→ 320,705 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+60,090→ 2,370,097 total

Companies

Acrivon Therapeutics, Inc.
Director, President and CEO
$ACRV

Recent Filings

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472

View on SEC.gov